|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Notice to Readers: Update: Manufacturer's Recall of Rapid Cartridge Assay Kits on the Basis of False-Positive Cryptosporidium Antigen TestsOn March 23, this notice was posted as an MMWR Dispatch on the MMWR website (http://www.cdc.gov/mmwr). On March 4, 2004, CDC announced that a manufacturer had voluntarily recalled rapid cartridge assay kits because of false-positive Cryptosporidium antigen tests (1). An additional lot of a Cryptosporidium/Giardia rapid assay has been recalled voluntarily from laboratories by the distributor (Meridian Bioscience, Inc., Cincinnati, Ohio) on the basis of their findings that Cryptosporidium-negative samples were weakly reactive with this lot (ImmunoCard STAT!®, lot no. 081138 [expires October 5, 2004]). CDC recommends reconfirmation of positive test results (by using direct fluorescent antibody testing or modified acid-fast stained smears) obtained with ImmunoCard STAT!® rapid assays from all recalled lots. Reference
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 3/25/2004 |
|||||||||
This page last reviewed 3/25/2004
|